Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2263.HK
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -98.83 3.36 286.02
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -28.90 -132.01 -102.41
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 0.06 0.35 0.35
Cash 64.30 0.34 0.20
Capex -100.11 < 0.005 < 0.005
Free Cash Flow 70.39 0.06 0.04
Revenue 152.92 0.02 < 0.005
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -9.19 0.91 1.00
Operating Margin -37.94 0.09 -0.15
ROA 100.00 < 0.005 < 0.005
ROE 100.00 < 0.005 < 0.005
ROIC 21.19 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2263.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2263.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2263.HK is permitted for members.